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Abstract
Background: Alveolar echinococcosis (AE) is characterized by the tumor-like growth of Echinococcus (E.) multilocularis. Very
little is known on the influence of helminth parasites which develop in the liver on the proliferation/growth arrest metabolic
pathways in the hepatocytes of the infected liver over the various stages of infection.
Methodology/Principal Findings: Using Western blot analysis, qPCR and immunohistochemistry, we measured the levels of
MAPKs activation, Cyclins, PCNA, Gadd45b, Gadd45c, p53 and p21 expression in the murine AE model, from day 2 to 360
post-infection. Within the early (day 2–60) and middle (day60–180) stages, CyclinB1 and CyclinD1 gene expression increased
up to day30 and then returned to control level after day60; Gadd45b, CyclinA and PCNA increased all over the period; ERK1/
2 was permanently activated. Meanwhile, p53, p21 and Gadd45c gene expression, and caspase 3 activation, gradually
increased in a time-dependent manner. In the late stage (day180–360), p53, p21 and Gadd45c gene expression were
significantly higher in infected mice; JNK and caspase 3 were activated. TUNEL analysis showed apoptosis of hepatocytes.
No significant change in CyclinE, p53 mRNA and p-p38 expression were observed at any time.
Conclusions: Our data support the concept of a sequential activation of metabolic pathways which 1) would first favor
parasitic, liver and immune cell proliferation and survival, and thus promote metacestode fertility and tolerance by the host,
and 2) would then favor liver damage/apoptosis, impairment in protein synthesis and xenobiotic metabolism, as well as
promote immune deficiency, and thus contribute to the dissemination of the protoscoleces after metacestode fertility has
been acquired. These findings give a rational explanation to the clinical observations of hepatomegaly and of unexpected
survival of AE patients after major hepatic resections, and of chronic liver injury, necrosis and of hepatic failure at an
advanced stage and in experimental animals.
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Introduction
The larval stage of the fox-tapeworm Echinococcus (E.) multi-
locularis is the causative agent of alveolar echinococcosis (AE), one
of the most dangerous parasitic disease of the northern hemisphere
[1]. AE is characterized by an infiltrative, destructive and tumor-
like growth of the E. multilocularis metacestode, usually affecting the
liver of natural intermediate hosts such as small rodents or the
human liver [2]. Clinical manifestations are results of both a slow
but continuous asexual proliferation of the metacestode and an
intense infiltration by macrophages, T lymphocytes, and fibro-
blasts/myofibroblasts around the parasite, eventually leading to
fibrosis and necrosis [3,4,5,6]. Clinical symptoms usually appear
many years after the first contact with the parasite eggs
(oncospheres); progression of the lesions is very slow and the
observed complications and liver dysfunction are the result of a
complex and often latent sequence of events. In the experimental
model of secondary E. multilocularis metacestode infection, which
well mimics the natural infection [7,8], according to its clinical
course AE is divided into 1) an early stage with tumor-like growth
of the metacestode and mild hepatic enlargement, 2) a middle
stage with invasive parasitic lesions and progressive hepatomegaly
and 3) an advanced/terminal stage (also called ‘‘late stage’’)
associated with invasion of other organs and/or metastases,
fibrosis of the lesions and cholestasis, which may cause secondary
liver cirrhosis with subsequent portal hypertension and eventually
impaired liver function [9]. We and others have shown in previous
studies that these clinical changes were accompanied by a typical
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followed by 2) a combined Th1 and Th2 profile, also characterized
by a markedly increased production of IL-10 [10], and finally 3) a
decrease in all types of cytokines associated with a deep
impairment of the immune response [11,12]. Changes with time
in a variety of other components/enzymes involved in the immune
response such as chemokines [13], proteins of the acute
inflammatory phase [14], and nitric oxide synthase [15] have also
been shown. However, despite the presence of well-known clinical
symptoms (hepatomegaly, liver necrosis) which evoked such
influence in patients with AE, until recently, little was known on
the influence of the metacestode on the hepatocytes of the
surrounding liver parenchyma.
The orderly progression of cells through the phases of the cell
cycle is governed by the sequential assembly and activation of
holoenzyme complexes [16]. The Mitogen-Activated Protein
Kinase (MAPK) pathway and cell cycle regulatory proteins,
including Cyclins, Cyclin-dependent kinases (Cdks), Cyclin-depen-
dent kinase inhibitor 1a (Cdkn1a or p21), growth arrest and DNA
damage-inducible 45(Gadd45a, Gadd45b and Gadd45c), partici-
pate in the regulation of cell cycle progression [17,18,19,20].
Importantly, CyclinD1, a regulator of cellular proliferation, is itself
regulated by ERK1/2 [21,22]. The Cip/Kip family member, p21
was shown to inhibit cell proliferation and activities of several
Cyclin-Cdk complexes in vitro [23,24]. Transcriptional regulation of
the p21 gene is controlled by the tumor suppressor protein p53
acting on the p53 responsive element in the distal region of the p21
promoter in response to intracellular signals such as DNA damage
[25,26]. Furthermore, Gadd45c is also a p53-regulated human
gene, which interacts with PCNA, a normal component of multiple
quaternary complexes, including the Cycling Cdks and the Cdk
inhibitor p21, which play a central role in DNA repair, growth
suppression and apoptosis [27,28,29]. In addition, the JNK and p38
cascades appear to be pro-apoptotic. Their activation, via MTK1/
MEKK4, is mediated by Gadd45c as was shown in response to
various external stresses including bacterial infection, hyperosmo-
larity, and UV irradiation; these cascades also appear to be closely
related to cell death [30,31,32].
Our previous study, using western blot technique, has shown
that metabolic pathways involved in liver proliferation and growth
arrest and especially the MAPKs system were specifically induced
by E. multilocularis growth. We observed that ERK1/2 and p38
were activated in the liver of AE patients and that ERK, JNK and
p38 were activated in rat primary hepatocytes during exposure to
E. multilocularis vesicle fluid (EmF) or E. multilocularis axenic culture
supernatant (EmCM) in vitro [33]. Furthermore, using microarray
and qPCR technique, we followed the time-course of E.
multilocularis infection from day30 to 180 after intrahepatic
injection of metacestode for the expression of genes involved in
the inflammatory/immune response as well as numerous meta-
bolic pathways specific to the liver. We found an increased
expression of Gadd45b (2.19 fold at day90; 4.49 fold at day180),
Gadd45c (3.98 fold at day60; 4.92 fold at day90 and 21.94 fold at
day180) and p21 (5.60 fold at day60; 4.42 fold at day180) in the
middle and late stages of E. multilocularis infection in mice [34].
Gadd45b gene was originally characterized as a primary
responder in myeloid differentiation induced by IL-6 [35]. More
recent studies have shown that Gadd45b, unlike two other
homologs (Gadd45a and c), plays an anti-apoptotic role and is
activated by TNF-a via NFkB [19]. Thus, induction of Gadd45b
coincides with the entry into an active cell cycle; its action might
be to protect hepatocytes from apoptosis in the middle stage. Then
induction of p21 and Gadd45c coincides with the entry into an
inhibitory phase regarding cell proliferation; its action might be to
promote hepatocyte growth arrest and/or apoptosis in the late
stage. However, the underlying mechanisms for the involvement of
the host liver MAPK signaling pathways, and of cell cycle
regulated proteins such as Cyclins, Gadd45b, p53, p21 and
Gadd45c in the progression of E. multilocularis-infected mice in vivo
are unknown to date. Their contribution to the hepatocyte
proliferation and growth arrest process which appears to
accompany E. multilocularis metacestode development is also
ignored.
The aims of the present study were thus, in the secondary
experimental murine model of AE, 1) to explore the influence of E.
multilocularis metacestode on components of cell cycle regulation
which characterize the host’s hepatic proliferation in the liver of
mice infected with E. multilocularis over a time period of 1yr, i.e.
from the date of E. multilocularis inoculation to the very late stage of
infection; 2) to simultaneously explore the activation of inhibitory
proteins involved in growth arrest/apoptosis metabolic pathways
during the 3 stages of infection. For these purposes, we measured
the levels of ERK1/2, JNK, p38 activation, Cyclins, PCNA,
Gadd45b, Gadd45c, p53 and p21 by western blot and qPCR and,
using immunohistochemistry we studied the same components in
relation to the pathological changes in the liver, both in the
infection site and in the neighboring liver parenchyma where
proteins and mRNAs were measured.
Results
Hepatic injury induced by E. multilocularis
As shown in Figure 1, from day30 to 180 post-infection, the
typical pathological changes which characterize E. multilocularis
lesions were observed in the liver of the mice infected with E.
multilocularis; at days 2 and 8, only infiltrating lymphocytes,
surrounding E. multilocularis inoculum, could be observed; at days
270 and 360 post-infection, the pseudo-tumor parasitic mass
included many vesicular and/or cystic structures embedded within
thick fibrous tissue, the periparasitic area was composed of
inflammatory fibrous tissue and necrotic areas and mixed with
small granulomatous nodules [34]. The hepatic parenchyma close
to the lesions was progressively invaded by fibrous connective
tissue septa, and solitary islands of hepatic tissue were observed. At
the same time points, no hepatic injury was observed in the mice
of the control groups (Figure 1).
Activation of MAPKs in the liver of mice during
E. multilocularis infection
As shown in Figure 2A and 2B, western blotting showed
increased ERK1/2 phosphorylation (p-ERK1/2) from day2
(,1.40-fold) to 360(,2.78-fold); it peaked at day180 (,5.69-fold);
there was a significant difference between E. multilocularis infected
and non-infected mice at day90 post-infection (P , 0.05), and
increased JNK phosphorylation (p-JNK) from day180 (,1.89-fold)
to 360 (,1.85-fold); it peaked at day270 (,2.19-fold) post-
infection; it was significantly different between E. multilocularis-
infected and non-infected mice at all time points since day180 (P ,
0.05). Interestingly, no phosphorylated-p38 (p-p38) was observed
in liver during the course of infection. As shown in Figure 2C, in
the lesion area, p-ERK1/2 was expressed in a few hepatocytes at
days 2 and 8 while there was no positive staining in the
inflammatory response zone. At days 30 and 60 the intensity of
the immunostaining increased, showing p-ERK1/2 localization in
infiltrating lymphocytes and fibroblast-like cells. At days 90, 180
and 270, the staining was more intense in the infiltrating
lymphocytes, and then decreased at day360. Within the liver
parenchyma close to the lesion and peri-parasitic infiltrate, p-
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and 180, the number of hepatocytes which expressed p-ERK1/2
progressively increased, with staining intensities from ‘‘weak’’ to
‘‘moderate’’; then p-ERK1/2 expression in hepatocytes decreased
at day360. No liver cell positive for p-ERK1/2 immunostaining
were observed in the liver of non-infected mice.
Expression of Gadd45b in the liver of mice during
E. multilocularis infection
As shown in Figure 3A and 3B, western blotting showed
increased Gadd45b expression from day60 (,1.75-fold) to 360
(,2.52-fold); it peaked at day180 (,62.64-fold) post-infection;
there was a significant difference between E. multilocularis-infected
and non-infected mice at days 60 and 180 (P , 0.05). Gadd45b
mRNA expression was increased from day2 (,1.27-fold) to 360
(,1.81-fold); it peaked at day 90 (,3.28-fold) post-infection
(Figure 3C). There was a significant difference between E.
multilocularis infected and non-infected mice at days 60 and 90 (P
, 0.05). At day8, Gadd45b expression was observed in infiltrating
lymphocytes; it progressively increased in fibroblast-like cells and
infiltrating lymphocytes from day30 to 180 (Figure 3D). Within the
liver parenchyma close to the lesion and peri-parasitic infiltrate,
Gadd45b expression was observed in hepatocytes around the
portal and central veins at day30; it markedly increased at days 90
and 180 post-infection, with staining intensities from ‘‘moderate’’
to ‘‘strong’’; then Gadd45b expression in hepatocytes mildly
decreased at days 270 and 360. No liver cell positive for Gadd45b
was observed in the livers of non-infected mice.
Expression of Cyclins A, B1, D1 and E in the liver of mice
during E. multilocularis infection
Asshown inFigure 4A and 4B, westernblottingshowed increased
Cyclin A expression from day2 (,1.52-fold) to 270 (,1.63-fold); it
peakedatday60(,8.46-fold),andthendecreasedunderthebaseline
at day360 (,0.86-fold) post-infection. There was a significant
difference between E. multilocularis infected and non-infected mice at
days 8, 30, 60, 90 and 180 (P , 0.05). Increased Cyclin B1
expression was observed at days 2 (,6.53-fold) and 8 (,3.71-fold); it
then decreased to the baseline from day 30 to 360 post-infection.
There was a significant difference between E. multilocularis infected
and non-infected mice at days 2 and 8 (P , 0.05). Increased Cyclin
D1 expression was observed at days 8 (,2.07-fold) and 30 (,1.41-
fold); it then decreased under the baseline from day60 to 360 post-
infection. There was a significant difference between E. multilocularis
infected and non-infected mice at days 8 and 30 (P , 0.05). Mild
increase in Cyclin E expression was observed from day 2 (,1.44-
fold) to 180 (,1.30-fold), but no significant difference was found
during the whole time-points (P . 0.05).
Cyclin A mRNA expression was increased from day2 (,1.62-
fold) to 180 (,1.35-fold) and then decreased under the baseline at
days 270 and 360; it peaked at day30 (,2.65-fold) post-infection
(Figure 4C). There was a significant difference between E.
multilocularis infected and non-infected mice at day30 (P , 0.05).
Cyclin B1 mRNA expression was increased at day 2 (,2.17-fold); it
then decreased to the baseline from day30 to 360 post-infection.
However,therewasnosignificantdifferencebetweenE.multilocularis
infected and non-infected mice (P . 0.05). Cyclin D1 mRNA
expression was increased from day2 (,1.41-fold) to 30 (,2.34-fold);
then it decreased under the baseline from day 60 to 360 post-
infection. There was a significant difference between E. multilocularis
infected and non-infected mice at day8 (P , 0.05). Cyclin E mRNA
expression was mildly increased at days 2 (,1.30-fold), 8 (,1.25-
fold) and 180 (,1.64-fold), but no significant difference was found
during the whole course of infection (P . 0.05).
Expression of PCNA in the liver of mice during
E. multilocularis infection
As shown in Figure 5A and 5B, western blotting showed
increased PCNA expression from day8 (,1.49-fold) to 180
(,2.52-fold) which peaked at day90 (,2.54-fold) post-infection;
it then decreased to the baseline at days 270 (,1.33-fold) and 360
(,1.19-fold). There was a significant difference between E.
multilocularis-infected and non-infected mice at days 30, 60, 90
and 180 (P , 0.05). PCNA mRNA expression was increased from
day8 (,2.06-fold) to day90 (,3.74-fold); it peaked at day90
(Figure 5C), then decreased to the baseline from day180 to 360.
There was a significant difference between E. multilocularis infected
and non-infected mice at days 8, 60 and 90 post-infection (P ,
0.05). As shown in Figure 5D, immunohistochemistry showed an
increased expression of PCNA in the hepatocytes of E. multilocularis
infected and non-infected mice at days 2 and 8, then no PCNA
expression was observed in the liver of non-infected mice;
increased expression of PCNA was observed since day 8 until
day180 in infected mice.
Figure 1. Representative histopathology of mice liver during E. multilocularis infection. (a–h): No morphological changes were observed in
the liver of control mice. (i–p): Proliferating hepatocytes close to the parasitic lesions were observed from days 2 to 180 (thin arrow) and some
coagulation necrosis areas (thick arrow) close to the parasitic lesions were observed from days 180 to 360 in the liver from E. multilocularis infected
mice. The arrowheads indicate the parasitic lesions in the liver of infected mice (‘‘lesion’’ row); the lesions had the typical aspect of E. multilocularis
germinal layer and laminated layer, surrounded by a periparasitic cell infiltrate composed mostly, from the center to the periphery, of macrophages
and fibroblasts/myofibroblasts, and lymphocytes. Final magnification, 2006. con, control, non-infected mice; Em, E. multilocularis infected mice.
doi:10.1371/journal.pone.0030127.g001
Hepatocyte Proliferation/Apoptosis in Murine AE
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30127Expression of p53 in the liver of mice during
E. multilocularis infection
As shown in Figure 6A and 6B, western blotting showed
increased p53 expression at days 60 (,2.63-fold), 90 (,4.11-fold),
270 (,3.13-fold) and 360 (,2.77-fold); it peaked at day360 post-
infection. There was a significant difference between E. multi-
locularis-infected and non-infected mice at days 90, 270 and 360 (P
, 0.05). As shown in Figure 6C, no significant change of p53
mRNA expression was observed at any time-point.
Expression of p21 in the liver of mice during
E. multilocularis infection
As shown in Figure 7A and 7B, western blotting showed
increased p21 expression from day60 (,1.84-fold) to 360 (,8.15-
fold); it peaked at day360 post-infection. The difference between
E. multilocularis-infected and non-infected mice was significant at
days 180, 270 and 360 (P , 0.05). As shown in Figure 7C, p21
mRNA expression, despite its increase from day30 (,3.21-fold) to
360 (,4.06-fold), was significantly different from that measured in
non-infected mice when it peaked at day270 post-infection
(,9.01-fold) (P , 0.05). As shown in Figure 7D, in the lesion
area, p21 expression was observed in infiltrating lymphocytes and
fibroblast-like cells at day180; it progressively increased from
day270 to 360. Within the liver parenchyma close to the lesion
and peri-parasitic infiltrate, p21 expression was observed in
hepatocytes close to the lesion at day180. A marked increase in
the liver cell expression of p21 was observed at days 270 and 360
post-infection, with staining intensities from ‘‘weak’’ to ‘‘moder-
ate’’.
Figure 2. Activation of MAPKs in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates from
liver samples with antibodies that recognize phosphorylated (p-) and total ERK1/2, JNK and p38 respectively (A). Relative amount of phosphorylated
and total ERK1/2, JNK and p38 was calculated from semi-quantitative analysis of the Western blots using densitometry (B). Histo-immunochemical
analysis of p-ERK1/2 expression was performed on tissue samples: p-ERK1/2 expression was observed in infiltrating lymphocytes (lesion) and
fibroblast-like cells (lesion) but also in hepatic cells (close to lesion) in the liver from E. multilocularis infected mice (arrow) (C). The arrowheads indicate
the parasitic lesions in the liver of infected mice (‘‘lesion’’ row). Final magnification, 4006.
*P,0.05 versus control. con, control, non-infected mice; Em,
E. multilocularis infected mice; AU: arbitrary units; lesion: E. multilocularis metacestode and surrounding immune infiltrate; close: liver parenchyma
close to E. multilocularis lesion.
doi:10.1371/journal.pone.0030127.g002
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As shown in Figure 8A, before day60, Gadd45c mRNA
expression was unchanged; it then increased from day60 (,3.23-
fold) to 360 (,3.47-fold) and peaked at day180 (,7.86-fold)
post-infection; it was significantly different between E. multi-
locularis-infected and non-infected mice at days 180 and 360
post-infection (P , 0.05). As shown in Figure 8B, Gadd45c
expression was observed in periparasitic infiltrating lymphocytes
at day180; it increased inside the lesion at days 270 and 360.
Within the liver parenchyma close to the lesion and peri-
parasitic infiltrate, Gadd45c expression was observed at day90
and markedly increased at days 180, 270 and 360 post-infection,
with staining intensities from ‘‘moderate’’ to ‘‘strong’’. No liver
cell positive for Gadd45c was observed in the livers of non-
infected mice.
Activation of caspase 3 in the liver of mice during
E. multilocularis infection
Caspase 3 activation, a marker of the apoptotic protease
cascade, was measured by western blotting, qPCR and immuno-
histochemistry. As shown in Figure 9A which shows immunoblot-
ting with anti-caspase 3 (35kDa) and anti-cleaved caspase 3 (17
and 19kDa), cleaved caspase 3 was significantly increased at days
90, 270 and 360 post-infection. As shown in Figure 9B, before
day60, caspase 3 mRNA level was unchanged; it then increased
from day60 (,1.43-fold) to 270 (,2.98-fold), peaked at day90
(,3.70-fold), and decreased to the baseline at day360. There was a
significant difference between E. multilocularis-infected and non-
infected mice at day180 post-infection (P , 0.01). As shown in
Figure 9C, in the periparasitic infiltrate, caspase 3 and cleaved-
caspase 3 expression were observed in the lymphocytes at day90; it
then increased inside the lesion from day180 to 360. Within the
Figure 3. Gadd45b expression in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates from
liver samples with antibodies that recognize Gadd45b (A). Relative amount of Gadd45b expression was calculated from semi-quantitative analysis of
the Western blots using densitometry (B). Gadd45b mRNA expression was measured by qPCR (C). Histo-immunochemical analysis of Gadd45b
expression was performed on tissue samples: Gadd45b expression was observed in infiltrating lymphocytes (lesion) but also in hepatic cells (close to
lesion) in the liver from E. multilocularis infected mice by histo-immunochemical analysis (arrow) (D). The arrowheads indicate the parasitic lesions in
the liver of infected mice (‘‘lesion’’ row). Final magnification, 4006.
*P,0.05 versus control. con, control, non-infected mice; Em, E. multilocularis
infected mice; AU: arbitrary units; lesion: E. multilocularis metacestode and surrounding immune infiltrate; close: liver parenchyma close to E.
multilocularis lesion.
doi:10.1371/journal.pone.0030127.g003
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caspase 3 and cleaved-caspase 3 expression was observed at days
60 and 90; it then markedly increased at days 270 and 360 post-
infection, with staining intensities from ‘‘moderate’’ to ‘‘strong’’.
Minimal immunostaining for caspase 3 and cleaved-caspase 3 was
observed in the livers of non-infected mice.
TUNEL-positive cells in the liver of mice during
E. multilocularis infection
To determine whether cells exhibited DNA strand breakage
during E.multilocularis infection, and could thus be considered
apoptotic, the TUNEL assay was applied to the liver sections. As
shown in Figure 10, in the periparasitic infiltrate, some
inflammatory cells with apoptosis were observed inside the lesion
at days 180, 270 and 360. Within the liver parenchyma close to
the lesion and peri-parasitic infiltrate, a few hepatocytes exhibiting
apoptosis were observed at day180; the number of apoptotic
hepatocytes significantly increased in a time-dependent manner up
to day360 post-infection; during the late stage of infection,
TUNEL staining intensities ranged from ‘‘weak’’ to ‘‘moderate’’.
No apoptotic liver cells were observed in the livers of the non-
infected mice.
Discussion
Changes in the metabolic pathways involved in the regulation of
hepatic cell proliferation and growth arrest, and especially in the
MAPKs system, have been extensively studied in infectious/
inflammatory conditions, especially of viral origin [36,37,38]. Very
little is known of the influence of helminth parasites which develop
in the liver on the proliferation/growth arrest of the hepatocytes in
the infected liver. Until recently, no study had ever specifically
addressed the issue of liver proliferation/regeneration and growth
Figure 4. Cyclins A, B1, D1 and E expression in the liver of mice during E. multilocularis infection. Western blot analyses were performed
on lysates with antibodies that recognize cyclins A, B1, D1 and E (A). Relative amount of cyclins A, B1, D1 and E expression was calculated from semi-
quantitative analysis of the Western blots using densitometry (B). Cyclins A, B1, D1 and E mRNA expression was measured in the liver from E.
multilocularis infected or non-infected mice by qPCR(C).
*P,0.05 versus control. con, control, non-infected mice; Em, E. multilocularis infected mice;
AU: arbitrary units.
doi:10.1371/journal.pone.0030127.g004
Figure 5. PCNA expression in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates with
antibodies that recognize PCNA (A). Relative amount of PCNA expression was calculated from semi-quantitative analysis of the Western blots using
densitometry (B). PCNA mRNA expression was measured by qPCR (C) and PCNA expression by hepatic cells (close to lesion) in the liver from E.
multilocularis infected or non-infected mice by histo-immunochemical analysis(arrow) (D). Final magnification, 4006.
*P,0.05 versus control. con,
control, non-infected mice; Em, E. multilocularis infected mice; AU: arbitrary units.
doi:10.1371/journal.pone.0030127.g005
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study using the murine experimental model of E. multilocularis
infection, we could show that, opposite to those involved in cell
proliferation and anti-apoptosis which were activated in the first
half of the infection course, metabolic pathways involved in growth
arrest and apoptosis were significantly activated in the liver of the
infected mice in the second half of the infection course (Figure 11).
In the present study, we could confirm the induction of p-
ERK1/2 and a parallel expression of Cyclin D1 and PCNA from
the beginning of infection and their persistence during the
progression of E. multilocularis growth in the liver during the first
2 stages of parasite development. This suggested that, as shown in
other models, activation of the ERK1/2 pathway increased
hepatocyte DNA synthesis and was involved in the activation of
cell cycle [39,40,41]. Increased expression of PCNA in the hepatic
cells under the influence of E. multilocularis was constantly found in
vivo, in previous studies [33,34] and in this study as well. PCNA is a
stable cell cycle-related 36 kDa nuclear protein which is
increasingly expressed in late G1 and throughout S phase of the
cell cycle. Its rate of synthesis is correlated with the proliferative
rate of cells, and PCNA immunoblot and immunostaining can be
used to reliably define and map proliferating cells in animal and
human tissues [42,43]. Expression of PCNA in the liver
hepatocytes of both infected and non-infected mice at days 2
Figure 6. p53 expression in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates from liver
samples with antibodies that recognize p53 (A). Relative amount of p53 expression was calculated from semi-quantitative analysis of the Western
blots using densitometry (B). p53 mRNA expression was measured in the liver from E. multilocularis-infected or non-infected mice by qPCR (C).
*P,0.05 versus control. con, control, non-infected mice; Em, E. multilocularis infected mice; AU: arbitrary units.
doi:10.1371/journal.pone.0030127.g006
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by the injection in the liver, which constitutes, per se, a liver injury.
In our study, qPCR confirmed that intrahepatic PCNA synthesis
was more increased in E. multilocularis-infected mice than in non-
infected mice as early as day8, and that PCNA synthesis increase
was also correlated with E. multilocularis development until day180.
Then we also found that the induction of p-JNK induced by
metacestode components we observed in vitro in a previous study
[33] began at the end of the middle stage of infection and remained
markedly increased at its late stage (up to 1 year). Such activation
paralleled an up-regulation of p53, p21, Gadd45c, an increased
expression of cleaved-caspase 3, an increase in the number of
TUNEL-positive (apoptotic) cells in the lesion and in the liver
parenchyma, and a down-regulation of PCNA and Cyclin A.
Activation of the metabolic pathways which govern growth arrest
and apoptosis also paralleled the previously described decrease of
lymphocyte proliferation and ofcytokineproductionobservedatthe
late stage of experimental infection [10,11,12].
Accumulated data have suggested that the stress- and cytokine-
inducible Gadd45 family proteins (Gadd45a, Gadd45b, Gadd45c)
serve similar but not identical functions along various pro- or anti-
apoptotic and growth-suppressive pathways [44]. Gadd45b, which
interacts with critical cell cycle regulatory proteins, such as PCNA,
Cdk1 and Cyclin B1, plays an active role in cell cycle adjustment
[27,35,45]. From our previous microarray analysis, we could
observe Gadd45b up-regulation at days 90 and 180 in the murine
AE model [34], which highly suggested that up-regulated
expression of Gadd45b gene might actually be a trigger for
hepatic cell survival. Our present study showed that Gadd45b
mRNA was significantly increased from day60 to 180. Both
immunostaining and immunoblotting confirmed that Gadd45b
protein was actually expressed in the liver during the same period,
especially in the vicinity of the metacestode. Interestingly,
Gadd45b is able to inhibit TNF-a-induced cytotoxicity and Fas-
induced apoptosis [19,46,47], both of which were showed to be
expressed at the periphery of the periparasitic granuloma, at the
border of the liver parenchyma, in human AE [3,48]. A recent
study has demonstrated that ERK and Gadd45b are closely
related to NF-kB activity, forming a loop-like connection to
increase cell survival after lethal damage induced by ionizing
Figure 7. p21 expression in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates from liver
samples with antibodies that recognize p21 (A). Relative amount of p21 expression was calculated from semi-quantitative analysis of the Western
blots using densitometry (B). p21 mRNA expression was measured by qPCR (C). Histo-immunochemical analysis of p21 expression was performed on
tissue samples: p21 expression was observed in infiltrating lymphocytes (lesion) and fibroblast-like cells (lesion) but also in hepatic cells (close to
lesion) in the liver from E. multilocularis infected mice (arrow) (D). The arrowheads indicate the parasitic lesions in the liver of infected mice (‘‘lesion’’
row). Final magnification, 4006.
*P,0.05 versus control. con, control, non-infected mice; Em, E. multilocularis infected mice; AU: arbitrary units; lesion,
E. multilocularis metacestode and surrounding immune infiltrate; close, liver parenchyma close to lesion.
doi:10.1371/journal.pone.0030127.g007
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activation of ERK1/2, Gadd45b and Cyclin A are able to interact
and promote hepatocyte anti-apoptosis at the middle stage of
infection. Gadd45c is a critical and essential mediator of apoptosis
induction among the three Gadd45 isoforms because Gadd45c
has strongly pro-apoptotic roles at all times [50]. Gadd45c may
interact with MTK1/MEKK4, which in turn activate both JNK
and p38 leading to apoptosis in response to environmental stresses
[51,52,53]. Our data obtained during the course of infection
suggested a sequential activation of, first, Gadd45b in the first
stages of infection, and, then, of Gadd45c in the late stage of
infection; however, the factors which are responsible for the shift to
Gadd45c expression after day180 of infection are unknown. Our
present study showed that, like Gadd45c expression, activation of
JNK was observed from day180 to 360. Generally, JNK acts as a
critical mediator of hypoxia/reoxygenation-induced apoptosis and
also of TNF-induced apoptosis by glutathione depletion in
hepatocytes [54,55]. Our data also suggest that p53-dependent
mechanisms (p53-p21 and p53-Gadd45c signaling pathways) may
be involved following E. multilocularis infection to induce hepato-
cyte growth arrest/apoptosis. Our data regarding TUNEL-
positive cells and elevation of cleaved-caspase 3 highly suggest
that hepatocyte apoptosis is a significant event at the late stage of
infection. These observations are consistent with the results of
previous studies which showed that apoptosis-mediated damage
was present in other parasitic diseases such as Chagas
’ disease,
toxoplasmosis, leishmaniasis, schistosomiasis due to Schistosoma
mansoni, and cerebral malaria [56,57,58,59,60]. Hepatocyte
apoptosis at the late stage of infection could result from either
toxic by-products originating from the parasite or from parasite-
induced inflammation. But unlike growth arrest/apoptosis, the
activation of hepatocyte proliferation/anti-apoptosis processes we
observed in the same experimental mice appears to be a less
common phenomenon, which could represent one of the
specificities of E. multilocularis infection at its early stages.
Hepatocytes suffering sublethal injury have the capacity to
activate an internally-triggered cell regeneration mechanism and
our previous studies as well as this one have brought evidence that,
as it also occurs during viral infection or toxic injury [61], this
regeneration mechanism was also operating in E. multilocularis
infection [33,34], and was especially prominent at the first stages
of infection, as was shown in experimental mice until day180 after
infection. Liver regeneration is controlled by a wide array of
signaling factors and plays a key role in recovery after acute and
chronic liver injury. Hepatic cell proliferation is essential to
enhance or restore hepatic function [62,63]. Although hepatocyte
proliferation is often mediated by the injury/regeneration
response, however, in other circumstances it is part of an adaptive
response to stress stimuli which do not lead to cell death (direct
hyperplasia). This proliferative response is regulated by cell cycle
regulated proteins [64]. In AE, influence of the parasite on
hepatocyte proliferation (and/or anti-apoptosis) is supported by
the up-regulation of Cyclins A, B1, D1 and Gadd45b, which is
summarized in Figure 10. Until day180, i.e. in the early and
Figure 8. Gadd45c expression in the liver of mice during E. multilocularis infection. Gadd45c mRNA expression was measured by qPCR (A).
Histo-immunochemical analysis of Gadd45c expression was performed on tissue samples. Gadd45c expression was observed in infiltrating
lymphocytes (lesion) and hepatic cells (close to lesion) in the liver from E. multilocularis-infected or non-infected mice (arrow) (B). The arrowheads
indicate the parasitic lesions in the liver of infected mice (‘‘lesion’’ row). Final magnification, 2006.
*P,0.05 versus control. con, control, non-infected
mice; Em, E. multilocularis infected mice; AU: arbitrary units; lesion, E. multilocularis metacestode and surrounding immune infiltrate; close, liver
parenchyma close to E. multilocularis lesion.
doi:10.1371/journal.pone.0030127.g008
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PLoS ONE | www.plosone.org 10 January 2012 | Volume 7 | Issue 1 | e30127Figure 9. Activation of caspase 3 in the liver of mice during E. multilocularis infection. Western blot analyses were performed on lysates
from liver samples with antibodies that recognize caspase 3 and cleaved-caspase 3 (A). Caspase 3 mRNA expression was measured by qPCR (B). Histo-
immunochemical analysis of caspase 3 and cleaved-caspase 3 expression was performed on tissue samples. Caspase 3 and cleaved-caspase 3
expression was observed in infiltrating lymphocytes (lesion) and hepatic cells (close to lesion) in the liver from E. multilocularis-infected or non-
infected mice (arrow) (C). The arrowheads indicate the parasitic lesions in the liver of infected mice (‘‘lesion’’ row). Final magnification, 2006.
**P,0.01
versus control. con, control, non-infected mice; Em, E. multilocularis infected mice; AU: arbitrary units; lesion, E. multilocularis metacestode and
surrounding immune infiltrate; close, liver parenchyma close to E. multilocularis lesion.
doi:10.1371/journal.pone.0030127.g009
Figure 10. TUNEL assay in the liver during E. multilocularis infection. TUNEL assays were performed on the livers from E. multiloculari-infected
and non-infected mice. Some TUNEL-positive infiltrating lymphocytes (lesion) and hepatic cells(close to lesion) were found in the liver of infected
mice from day180 to 360; None was found at day60 and 90 (arrows). The arrowheads indicate the parasitic lesions in the liver of infected mice
(‘‘lesion’’ row). No TUNEL-positive cells were seen in the liver of non-infected mice. Final magnification, 4006. con, control, non-infected mice; Em, E.
multilocularis infected mice; AU: arbitrary units; lesion: E. multilocularis metacestode and surrounding immune infiltrate; close: liver parenchyma close
to E. multilocularis lesion.
doi:10.1371/journal.pone.0030127.g010
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increased in a time-dependent manner, while gene expression
levels of Cyclin B1 and CyclinD1 were increased up to day30 and
then returned to the control level after day60. On the other hand,
no significant change in the expression of Cyclin E was observed at
any time during the period of observation. Up-regulation of
PCNA, Cyclin D1, A and B1 is related to the regulation of the
G1/S and G2/M phases [65,66], which were previously reported
to increase biphasically after partial hepatectomy and other
parasitic infection [67,68]. The ‘‘late stage’’ of infection, i.e. after
day180 after infection, has rarely been studied in the murine
model of secondary (or primary) E. multilocularis infection. In the
most susceptible mice, impairment of vital functions due to E.
multilocularis progression and metastases is fast and occurs between
day180 and 270, which makes studies difficult to interpret. In
addition, most of the studies addressed immunological mecha-
nisms of immune tolerance; since they were just failing at that late
stage [10,11,12], it was thus considered of less interest for that
purpose. As the experimental mice we are working with, albeit
quite susceptible to E. multilocularis, have a prolonged survival until
day360, and because we observed activation of both proliferation
and apoptosis pathways at day180, we decided to measure the
expression and/or activation of the components of these pathways
until day360. We were thus able to show the mirror image of
growth arrest/apoptosis versus proliferation/anti-apoptosis during
the natural course of metacestode progression in the liver
(Figure 12). These results might suggest that the proliferative
capability of hepatocytes was exhausted during continuously
lasting hepatic damage, due to direct toxicity of parasitic
components and/or cytotoxic attacks by the immune system.
This exhaustion might also be due to the profound malnutrition
(wasting disease/cachexia) observed in E. multilocularis-infected
mice in the advanced stage of the disease, and the altered ability of
liver cells to synthesize proteins, as suggested by the changes in the
expression of many genes at this stage in the microarray analysis
we recently performed [34]. However, during the early and
middle stage of infection, despite the presence of the metacestode
and its growth, very little necrosis is observed on the liver
pathological sections in the experimental model; we could
confirm such observations [69]. Necrosis of the liver lesion is
not observed in all patients with AE: it has only been observed in
more advanced/severe cases, and was associated with suscepti-
bility markers and/or with expression of TNF-a by the
periparasitic macrophages [48]. On the other hand, the immune
tolerance generated by the presence of E. multilocularis metaces-
tode in the liver is associated with a poor development of NK
cytotoxicity and an inhibition of T-lymphocyte-dependent
cytotoxicity, despite the high proliferation potential of T-
lymphocytes, the presence of numerous CD8 T-lymphocytes in
the liver within the parasitic lesion, and the expression of the
appropriate ligands, such as MICA/B [70,71,72]. Such an
inhibition is possibly due to the combined influence of IL-10 and
TGF-b production [7,73,74]. In addition, hepatocytes do not die
but do proliferate in response to parasite growth at the early and
middle stages of infection, and we could observe a significant
increase in the expression and/or activation of the components of
the proliferation pathways by hepatic cells at that stage. Such
observations at least partially rule out a direct influence of
cytotoxic components, which would manifest itself at all stages of
parasite development. Similar ‘‘exhaustion’’ at the late stage of
the disease has also been observed for lymphocyte proliferation
and cytokine secretion in susceptible experimental mice
[10,11,12]. In patients with AE, incubation of peripheral blood
mononuclear cells with parasitic antigens has been shown to
induce significantly less proliferation in AE patients with severe
disease than in patients with abortive or surgically cured cases
[75]: taken together, these observations suggest a common
negative influence of parasitic components on all types of cell
Figure 11. Overall changes in the gene expression of cell proliferation/cell cycle proteins (a) and cell growth arrest/apoptosis
proteins (b) during the process of E. multilocularis-induced liver injury in mice.
doi:10.1371/journal.pone.0030127.g011
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stage of E. multilocularis development.
From day90 to 180 after infection, in the BALB/c mice, AE
vesicles have become fully fertile and exhibit a number of
protoscoleces; it might be hypothesized that this period represents
the critical phase when the maturation of the metacestode has
been achieved and after which the host is no longer required to
promote parasite growth and fertility. In our experiments, day90
and 180 represented the critical steps when we still observed
expression of the proliferation pathway components and peaks in
the expression/activation of anti-apoptotic pathway components,
as well as beginning of increase in the expression/activation of
growth arrest/apoptotic pathway components. Then, growth
arrest/apoptotic pathways clearly overcome proliferation/anti-
apoptotic pathways. Our previous in vitro experiments showed that
such sequential events were not associated with any non-specific
‘‘exhaustion’’, which could only be observed in vivo. They strongly
suggested that they are governed by components of parasitic
origin: activation of such pathways was observed in isolated
hepatocytes under the influence of components present in the
vesicle fluid and in the supernatants of metacestode axenic cultures
[33]. Future work should elucidate the nature of these components
which would act in a sequential manner: 1) at the early stage and
beginning of the middle stage of E. multilocularis infection, they
would favor parasitic cell, liver cell and immune cell proliferation
and survival, and promote metacestode fertility and tolerance by
the host, and 2) after fertility has been acquired, at the end of
middle stage and all late stage of infection, they would contribute
to the dissemination of the protoscoleces and next steps of the
parasite cycle by favoring liver damage/apoptosis and subsequent
major impairment in protein synthesis and xenobiotic metabolism
[34], as well as immune deficiency [10,11,12,75], and eventually
lead to the host’s death.
In conclusion, this study is the first report which demonstrates a
coordinated activation of the proliferation/anti-apoptosis and
growth arrest/apoptosis mechanisms in vivo during the course of E.
multilocularis infection. As suggested in a schematic diagram
(Figure 12): 1) at the early stage of infection, activation of
ERK1/2 and downstream targets such as CyclinD1, A, B1 and
PCNA would favor hepatocyte proliferation, 2) at the middle stage
of infection, permanent activation of ERK1/2 and Cyclin A and
elevated Gadd45b expression may synergize to mediate an anti-
apoptotic response to enhance liver cell survival and prevent lethal
tissue damage induced both by the parasite itself and cytokines
Figure 12. Schematic diagram summarizing the metabolic pathways involved in hepatocyte proliferation/anti-apoptosis and
growth arrest/apoptosis in the liver of mice with E. multilocularis infection.
doi:10.1371/journal.pone.0030127.g012
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JNK and the increased expression of p53, p21, Gadd45c and
cleaved-caspase 3 would induce hepatocyte growth arrest/
apoptosis. These findings also give a rational explanation to the
clinical observations: 1) hepatomegaly of unusual size is frequent at
presentation; and an unexpected survival rate is observed after
major hepatic resection in AE patients [76], and 2) chronic liver
injury, necrosis, and hepatic failure in AE patients at an advanced
stage and in experimental animals [6,9]. They provide a molecular
basis for the balance between liver damage and repair in the
progression of E. multilocularis infection.
Materials and Methods
Ethics Statement
All animals received humane care in compliance with the
Medical Research Center’s guidelines, and animal procedures
were approved by the Animal Care and Use Committee and the
Ethical Committee of First Affiliated Hospital of Xinjiang Medical
University (20081205-2).
Experimental design
Pathogen-free female BALB/c mice (8–10 weeks old) were
purchased from the Animal Center of Xinjiang Medical University
and were maintained in an air-conditioned animal room with a
12-h light/dark cycle and provided with rodent chow and water.
E. multilocularis metacestodes were obtained from intraperitoneal
lesions maintained in Meriones unguiculatus, and 0.1 mL of pooled
lesions (,1, 000 protoscoleces) was injected into the anterior liver
lobe of infected mice as previously described [69]. For each
autopsy time-point, ten experimentally infected mice were used in
E. multilocularis group (n=10) and compared with five control mice
(n=5), which received an intra-hepatic injection of 0.1 mL of
saline in the anterior liver lobe using the same surgical procedure.
Mice were killed at days 2, 8, 30, 60, 90, 180, 270 and 360.
Tissue sampling
In E. multilocularis infected mice, liver tissue samples were taken
close to the parasitic lesions, i.e. 1–2mm from the macroscopic
changes due to the metacestode/granuloma lesion (white-yellowish
color), thus avoiding liver contamination with parasitic tissue and
infiltrating immune cells; in control mice, liver tissue samples were
taken from the same (anterior) liver lobe in the sham-injected area.
Tissue fragments were separated into two parts and either deep-
frozen in liquid nitrogen for western blot and qPCR or formalin-
fixed for immunohistochemistry. In addition, liver tissue samples
were also taken from the parasitic lesion (including periparasitic
liver tissue adjacent by 1 mm to the macroscopically visible
parasitic lesion) for histopathology and immunohistochemistry.
Pathology and parasitology
For histopathology livers were placed in 10% buffered formalin
and then embedded in paraffin. Five micrometer thick microtome
sections were prepared from each liver sample and stained with
hematoxylin-eosin. The sections were examined for the patholog-
ical changes generated by E. multilocularis and for hepatotoxicity.
The histological slides were evaluated blindly by two of the
authors.
Western blot analysis
Western blot analysis of cell lysates was performed by SDS-
PAGE using NuPAGE (Invitrogen, California, USA) followed by
transfer to PVDF membrane. Using the appropriate antibodies:
against total and p-ERK1/2, p-JNK, p-38 (dilution 1:500, Cell
Signaling technology, Massachusetts, USA), Gadd45b (dilution
1:800), Cyclins A, B1, D1 and E (dilution 1:500), PCNA (dilution
1:1000), p53, p21 (dilution 1:500, Santa Cruz, California, USA),
full length caspase 3 (35kDa) and large fragment of caspase 3
resulting from cleavage (17kDa) (dilution 1:500, Cell Signaling
technology, Massachusetts, USA), and GAPDH (dilution 1:1000,
Santa Cruz, California, USA) were detected using the Wester-
nBreeze Kit (Invitrogen, California, USA). The expression levels
of respective proteins (in ‘‘relative units’’) in non-infected mice and
infected mice were quantified using Quantity One software (Bio-
Rad, Hercules, CA), according to a previously described
procedure [77].
Quantitative real-time PCR analysis (qPCR)
After removing contaminated DNA from the isolated RNA
using DNaseI (Fermentas, Vilnius, Lithuania), 1 mg of total RNA
was reverse transcribed into cDNA in 20 mL reaction mixtures
containing 200U of Moloney murine leukemia virus reverse
transcriptase (MMLV, Promega, Madison, USA); 100 ng per
reaction of oligo (dT) primers; and 0.5mM each of dNTPs, dATP,
dCTP, dGTP, and dTTP. The reaction mixture was then
incubated at 42uC for 1 hour and at 95uC for 5 min to deactivate
the reverse transcriptase.
The qPCR was run in a thermocycler (iQ5 Bio-Rad, Hercules,
CA) with the SYBR Green PCR premix (TaKaRa, Dalian, China)
following the manufacturer’s instructions. Thermo-cycling was
performed in a final volume of 20 mL containing 2 mL cDNA and
10 pmol of each primer (Table 1). To normalize for gene
expression, mRNA expression of the housekeeping gene beta-actin
was measured. For every sample, both the housekeeping and the
target genes were amplified in triplicate using the following cycle
scheme: after initial denaturation of the samples at 95uC for
1 min, 40 cycles of 95uC for 5 s and 60uC (or other) for 30 s were
performed. Fluorescence was measured in every cycle, and a
melting curve was analyzed after the PCR by increasing the
temperature from 55 to 95uC (0.5uC increments). A defined single
peak was obtained for all amplicons, confirming the specificity of
the amplification.
Immunohistochemical staining
Paraffin-embedded liver tissue samples of control mice and
infected mice were examined to determine the expression and
distribution of p-ERK1/2, Gadd45b, PCNA, p21, Gadd45c,
caspase 3 and cleaved-caspase 3 protein at each time points. All
sections were first deparaffinized and then incubated with 3%
hydrogen peroxide for 10 min to block the endogenous peroxidase
activity. After being washed with PBS and incubation for 1 hour
with 5% normal goat serum to reduce non-specific background
staining, the sections were incubated with the above mentioned
primary antibodies against p-ERK1/2 (dilution 1:50), Gadd45b
(dilution 1:100), PCNA (dilution 1:300), p21 (dilution 1:50),
Gadd45c (dilution 1:200), caspase 3 and cleaved-caspase 3(dilution
1:100) at 4uC overnight. Immunoreactive proteins were visualized
using the appropriate anti-IgG secondary antibodies labeled with
horseradish peroxidase (Santa Cruz, California, USA) and the
chromogen 39-diaminobenzidine (DAB, Zhongshan, Beijing,
China) as a substrate[5]. Negative controls were incubated without
primary antibodies but were otherwise subjected to all the
immunohistochemical procedures. Sections were examined mi-
croscopically for specific staining and photographs were taken
using a digital image-capture system (Leica, Solms, Germany); the
intensity of positive hepatocyte staining was classified on an
arbitrary scale including ‘‘negative’’, ‘‘weak’’, ‘‘moderate’’, and
‘‘strong’’ staining.
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Apoptosis in the livers of infected mice and non-infected mice
was further analyzed using a commercial kit (Roche, Mannheim,
Germany) based on the TdT-mediated dUTP-digoxigenin nick-
end labeling (TUNEL) of apoptotic cells. Five micrometer sections
of paraffin-embedded samples of liver were prepared as described
above. Sections were examined microscopically for specific
staining and photographs were taken using a digital image-capture
system (Leica, Solms, Germany) (the intensity of TUNEL-positive
hepatocyte staining was classed on an arbitrary scale from
‘‘negative’’ to ‘‘strong’’ staining).
Statistical analysis
All data were presented as the means with standard deviation
and analyzed using SPSS version 11.0 software (SPSS, Chicago,
IL, USA). Statistical significance was tested using the Student’s t
test; a P value of less than 0.05 was considered significant.
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Genbank
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Expected
Size
beta-actin NM_007393 F: 59-AACTCCATCATGAAGTGTGA-39 R: 59-ACTCCTGCTTGCTGATCCAC-39 56uC 248bp
PCNA NM_0110045 F: 59- GAGAGCTTGGCAATGGGAACA-39 R: 59-GGGCACATCTGCAGACATACTGA-39 60uC 185bp
CyclinA NM_009828 F: 59- AGCAGAAGAGACTCAGAAGAGG -39 R: 59- GATAGTCAAGAGGTGTCAGTGG -39 60uC 121bp
CyclinB1 NM_172301 F: 59- AGGAAGAGCAGTCAGTTAGACC -39 R: 59- CTGGAGGGTACATCTCCTCATA -39 60uC 248bp
CyclinD1 NM_007631 F: 59- GGGGACAACTCTTAAGTCTCAC -39 R: 59- CCAATAAAAGACCAATCTCTC -39 60uC 206bp
CyclinE NM_007633 F: 59- GAGCTTGAATACCCTAGGACTG -39 R: 59-CGTCTCTCTGTGGAGCTTATAGAC -39 60uC 245bp
Gadd45b NM_008655 F: 59- GAGGCGGCCAAACTGATGA-39 R: 59-TCGCAGCAGAACGACTGGA-39 60uC 128bp
p53 NM_001127233 F: 59- ATTGGGACCATCCTGGCTGTAG -39 R: 59- CGAGGCTGATATCCGACTGTGA -39 60uC 148bp
p21 NM_007669 F: 59-CTGTCTTGCACTCTGGTGTCTGA-39 R: 59-CCAATCTGCGCTTGGAGTGA-39 60uC 121bp
Gadd45c NM_011817 F: 59- TGGATAACTTGCTGTTCGTGGA-39 R: 59-CAGCAGAAGTTCGTGCAGTG-39 60uC 122bp
Caspase 3 NM_009810 F: 59- CTGCCGGAGTCTGACTGGAA-39 R: 59-ATCAGTCCCACTGTCTGTCTCAATG-39 60uC 97bp
doi:10.1371/journal.pone.0030127.t001
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